ã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã®å¹æã«å¦å®çãªä¸»å¼µã¯ããããããããã¾ã§ã«è¦ããã¨ã®ãªããã¿ã¼ã³ã®ãã®ãè¦ã¤ãã*1ãè¦ç´ããã°ä»¥ä¸ã®ããã«ãªããå¼ç¨å
ã®æ¡åããã«ããã°ãã[ã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã«]ã¨ã¦ãäºé²å¹æãããã¨å¤§ãã声ã§ã¯è¨ãã¾ãããã¨ããæ ¹æ ã¯ãã¤ã³ãã«ã¨ã³ã¶ç½¹æ£è
ã«ãããé«ãã¯ã¯ãã³æ¥ç¨®çã§ã¯ãªããã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã®æ·»ä»ææ¸ã§ããããã§ãããã£ã¦ä»¥ä¸ã®è¦ç´ã¯æ¡åããã®ä¸»å¼µã¨ã¯ç¡é¢ä¿ã§ããã®ã§è¨æ£ããã¨ã¨ãã«ãæ¡åããã«è¬ç½ªãããã¾ãããªããã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã®æ·»ä»ææ¸ã®ãã£ããã©ã®é¨åããããã¨ã¦ãäºé²å¹æãããã¨å¤§ãã声ã§ã¯è¨ãã¾ãããã¨çµè«ããã®ãä½åº¦ã質åãã¾ããããååãªçãã¯ããã ãã¾ããã§ãããã¡ãªã¿ã«æ·»ä»ææ¸ã«ã¯å¥å¸¸ç·æ§ã«ã¤ãã¦ã¯ãã¯ã¯ãã³ã®æå¹çã¯ï¼ï¼ï¼
ããæ½è¨ã»ç
é¢å
¥æä¸ã®é«é½¢è
ã«å¯¾ãã¦ã¯ããçºç
é»æ¢å¹æã¯ï¼ï¼ãï¼ï¼ï¼
ãã¤ã³ãã«ã¨ã³ã¶ãå¥æ©ã¨ããæ»äº¡é»æ¢å¹æã¯ï¼ï¼ï¼
ãã¨ããã¾ãã詳細ã¯ã³ã¡ã³ãæ¬ãåç
§ãã¦ãã ããã
ã«ããã®ï¼ï¼ã®ç é¢ã§ã®ãã¼ã¿ã§ã¯ãã¤ã³ãã«ã¨ã³ã¶ã®æ£è ãã(æ人)ã®ãã¡ãï¼ï¼ï¼ ã¯ã¤ã³ãã«ã¨ã³ã¶ã®ã¯ã¯ãã³ãæ¥ç¨®ãã¦ãããããã§ã¯ã¯ã¯ãã³ã«äºé²å¹æãããã¨ã¯è¨ããªãã
ãã¦ãåé¡ãQ.ä¸è¨ã®ãã¼ã¿ããã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã®äºé²å¹æã®æç¡ã«ã¤ãã¦å¤æã§ãããï¼
ã«ããã®ï¼ï¼ã®ç é¢ã§ã®ãã¼ã¿ã®åºæã¯ãMcGeer et.al, Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada., Clin Infect Dis. 45(12):1568-75.ã ã2007å¹´ã®è«æã§ãæ°åã¤ã³ãã«ã¨ã³ã¶ã§ã¯ãªããå£ç¯æ§ã¤ã³ãã«ã¨ã³ã¶ã®è©±ã§ããã主é¡ã¯ãæã¤ã³ãã«ã¨ã³ã¶è¬ã¯ã¤ã³ãã«ã¨ã³ã¶ã«ããå ¥é¢æ£è ã®æ»äº¡ãæ¸ãããã¨ãããã®ãåèã«ããã£ãããã¤ã³ãã«ã¨ã³ã¶ã«ããæäººå ¥é¢æ£è 327人ä¸ãã¯ã¯ãã³æ¥ç¨®è ã¯216人ï¼71%ï¼ã¨ããã æ³åããã«ãä¸è¨è¦ç´å¼ç¨ããçºè¨ãããæ¹ã¯ããããã¯ã¯ãã³ã«äºé²å¹æãããã®ã§ããã°ãã¤ã³ãã«ã¨ã³ã¶ã§å ¥é¢ãã人ã®7å²ãã®äººã«ã¯ã¯ãã³æ¥ç¨®æ´ãããã®ã¯ãããããã¯ã¯ãã³ãã¤ã³ãã«ã¨ã³ã¶ãäºé²ããã®ã§ããã°ãå ¥é¢ã¨ãªã£ã人ã®ä¸ã®ã¯ã¯ãã³æ¥ç¨®è ã®å²åã¯ãã£ã¨ä½ããªãã¯ãã ãã¨ãèãã«ãªã£ãã®ã§ããã*2ãããããåæ§ã®è«çãç¨ãã¦ãã·ã¼ããã«ãã«æ»äº¡ãé²ããªãã¨ã主張ã§ããã
å¹³æ20å¹´ã®æ¥æ¬ã®ãã¼ã¿ã§ã¯ãé転å¸ã«åº§ã£ã¦ãã¦äº¤éäºæ ã§æ»äº¡ãã人ã®ãã¡ãï¼ï¼ï¼ ã¯ã·ã¼ããã«ãããã¦ãããããã§ã¯ã·ã¼ããã«ãã«æ»äº¡ãäºé²ããå¹æãããã¨ã¯è¨ããªãã
è¦å¯åºã®ãã¼ã¸ã«ãã座å¸ä½ç½®å¥ã»ã·ã¼ããã«ãçç¨æç¡å¥æ»å·è æ°ã®è¡¨ã«ããã¨ãé転å¸ã«ãããæ»è æ°ã®ãã¡ãã·ã¼ããã«ãçç¨ã631人ãéçç¨ã605人ã§ãã£ã*3ãã¯ã¯ãã³ã®è©±ã¯ãããã«ããã¦ããã·ã¼ããã«ãã«å©ããã¨ããããããã¨æã£ãããã©ãããæ®æ®µããé転ãã¦ãã人ã®ã·ã¼ããã«ãçç¨çãé«ãã£ãããæ»è æ°ã®ãã¡ã®ã·ã¼ããã«ãçç¨è ã®å²åãé«ããªããä»®ã«ãé転è ã®ãã¹ã¦ãã·ã¼ããã«ããçç¨ãã¦ããã¨ããããé転å¸ã«åº§ã£ã¦ãã¦äº¤éäºæ ã§æ»äº¡ãã人ã®ãã¡100ï¼ ãã·ã¼ããã«ãçç¨è ã«ãªããã·ã¼ããã«ãã®å¹æãç¥ãããã®ã§ããã°ãå°ãªãã¨ãæ¯è¼å¯¾ç §ã¨ãªã群ã§ã®ã·ã¼ããã«ãçç¨çãå¿ è¦ã§ãããè¦å¯åºã®ãã¼ã¸ã§ã¯ãå¯¾ç §ç¾¤ãæ»å·è ãã¤ã¾ãæ»äº¡ã§ã¯ãªãæªæã§æ¸ãã 人ãå«ããéå£ã¨ããã·ã¼ããã«ããããªãã¨é転å¸ã§ã¯æ»äº¡ã®ç¢ºçã47.2åã«ãªãã¨ãã¦ãããå³å¯ã«ã¯ããã·ã¼ããã«ããããªããããªé転è ã¯ä¹±æ´ãªé転ããããããäºæ ãèµ·ãããã¨ãã«æ»äº¡ããããããªã©ã¨ãã£ã交絡å åãèæ ®ãã¦ããªãã ããããããã§ãã·ã¼ããã«ãã«æ»äº¡ãæå¶ããå¹æããããã¨ãçåã«æã人ã¯ããã¯ããªãã ãã*4ã
ã²ãããã£ã¦åé ã®åé¡ã®çããA.å ¥é¢æ£è ã«ãããã¯ã¯ãã³æ¥ç¨®è ã®å²åã ãã§ã¯ãã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã®äºé²å¹æã®æç¡ã«ã¤ãã¦å¤æã§ããªããå¯¾ç §ç¾¤ã¨ã®æ¯è¼ãå¿ è¦ã§ããããã®å ´åã¯ã大éæã«ã¯ãå¯¾ç §ã¨ãªã£ãç é¢ã®å»çåã®æ人éå£ãå¯¾ç §ã¨ãªããåèã«ã¯ã
The proportion of patients in this cohort who had been vaccinated against influenza was substantial but is lower than vaccination rates among the general population of Ontario.
ï¼è¨³ï¼ã¤ã³ãã«ã¨ã³ã¶ã®äºé²æ¥ç¨®ãåããæ£è ã®å²åã¯ç¸å½ãªãã®ã ã£ããããªã³ã¿ãªãªã®ä¸è¬éå£ã®ã¯ã¯ãã³æ¥ç¨®çããã¯ä½ãã£ãã
ã¨ãããã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ãå ¥é¢ãæ¸ãããã¨ã示åãã¦ãã*5ããã¨ãã¨ãã®è«æã®ä¸»é¡ã¯ãæã¤ã³ãã«ã¨ã³ã¶è¬ã®å¹æã§ãã£ã¦ãã¯ã¯ãã³ã¯ããã¾ã§ãã¼ã¿ã®ä¸ã¤ã«éããªããã¯ã¯ãã³ã®å¹æã¯æ¢ç¥ã®ãã®ã¨ãã¦æ±ã£ã¦ããã
Other research clearly demonstrates that influenza vaccination is effective in preventing influenza and cost-saving to the health care system.
ï¼è¨³ï¼ä»ã®ç 究ã¯ãã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ãã¤ã³ãã«ã¨ã³ã¶ãäºé²ãããã¨ã«å¹æçã§ãå¥åº·ç®¡çã·ã¹ãã ã®ã³ã¹ããæãããã¨ãæããã«ç¤ºããã
ã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ã®å¹æã«ã¤ãã¦ã¯ãç¡ä½çºäºéç²æ¤æ³ã§ã証æããã¦ããããã ããå
¥é¢ãæ»äº¡ãå®å
¨ã«é²ãããã§ã¯ãªããã·ã¼ããã«ãã交éäºæ
æ»ãå®å
¨ã«é²ããã¨ãã§ããªãã®ã¨åãã ããç§ãã¡ã¯ã¤ã³ãã«ã¨ã³ã¶ã¯ã¯ãã³ãæã£ã¦ããã®ã«ãæ¯å¹´å¦ç´ééã«ãªã£ããç§ã¯æ¯å¹´ç½¹ã£ããã¨ããçµé¨ã§ãã£ã¦ã¯ã¯ãã³ã®å¹æã«æççã«ãªã人ãããããã ãã¯ã¯ãã³ã®æ¥ç¨®çãé«ããã°é«ãã»ã©ãããããçµé¨ããã人ã¯å¢ãããæ¯è¼å¯¾ç
§è©¦é¨ããçµé¨ãéè¦ãã人ã¯ã身è¿ãªäººéãã·ã¼ããã«ãããã¦ããã®ã«ãé¢ããã交éäºæ
ã§äº¡ããªã£ãããã·ã¼ããã«ãã®å¹æã«ãæççã«ãªãããã·ã¼ããã«ãã«å®³ãããå¯è½æ§ãèæ
®ãã¹ããããªãã®ãããªã©ã¨è¨ãã¯ãããã®ã ããããé¡ããã°ã対ç
§ç¾¤ã¨ã®æ¯è¼ã¨ãã観ç¹ãæã¦ã人ãå¢ãã¾ãããã«ã
é¢é£è¨äº
â ãã»ç§å¦ãè¦æãç·´ç¿åé¡ï¼ããã¤ãªã©ãã¼ãå¿æ´ãµã¤ãããï¼
â ãã»ç§å¦ãè¦æãç·´ç¿åé¡ï¼ä¸çå»å¦æ°åå¦ä¼ã®è«æéããï¼
2010å¹´2æ10æ¥è¿½è¨
ã³ã¡ã³ãæ¬ããã³ã¯ããããã§ããé·æã³ã¡ã³ãã¯åæ ããªãå¯è½æ§ãããã¾ããç¶ãã¯ãã¡ãã§â
http://d.hatena.ne.jp/NATROM/20100210
*1:URL:http://miyatak.iza.ne.jp/blog/entry/1192887/allcmt/#C1276850
*2:ãã¨ããã³ã¹ã¨ãã¦ç´¹ä»ãããè«æã¨ä½ãé¢ä¿ãã¦ããã®ããã£ã±ããã¨ã®ãã¯ãã³ã¡ã³ãããã£ãããã®çºè¨è ããããã§ã¯ã¯ã¯ãã³ã«äºé²å¹æãããã¨ã¯è¨ããªããã¨çµè«ä»ããçç±ãæ¨æ¸¬ããã»ããé£ããåé¡ãããããªã
*3:URL:http://www.npa.go.jp/koutsuu/kikaku89/zikotoukei-date.pdf
*4:ç¡ä½çºå²ä»ä»å ¥è©¦é¨ãªã©ãããããªãã®ã§ã交絡å åã®å½±é¿ãå®å ¨ã«åãé¤ãã®ã¯å°é£ã ããããã§ãããç¨åº¦ã¯åãé¤ããæ¹æ³ã¯ããã ãã
*5:å ¥é¢ã®ãªã¹ã¯ãé«ã人ãã¯ã¯ãã³ãæ¥ç¨®ããå¾åããã£ãã¨ãããããã¨ãéå£ä¸ã®æ¥ç¨®çã¨å ¥é¢æ£è ã®æ¥ç¨®çãå¤ãããªãã¦ããã¯ã¯ãã³ã«å¹æããªãã¨ã¯è¨ããªã